These results demonstrated that TGFB1, CDKN2A, and CDC20 were significantly expressed in proliferative tumor cells, CTSS was most prominently expressed in B cells, while VIM was expressed in multiple cell types (Fig. 6D). The gene discussed is CDKN2A; the disease is neoplasm.